Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells

International Journal of Oncology

Volumn 37, Issue 6, 2010, Pages 1529-1536

  Jiang, Jiahua ^a   Sliva, Daniel ^a,b,c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Cell cycle; Invasiveness; MycoPhyto; uPA

Indexed keywords

BETA 1,3 GLUCAN; CELL CYCLE PROTEIN 20; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; TRANSCRIPTION FACTOR E2F1; UROKINASE;

AGARICUS BLAZEI; ANAPC2 GENE; ARTICLE; BIRC5 GENE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL INVASION; CELL MIGRATION; CKS1B GENE; CORIOLUS VERSICOLOR; CULLIN 1 GENE; CYCLIN H GENE; CYTOSTASIS; DIET SUPPLEMENTATION; DNA MICROARRAY; GANODERMA LUCIDUM; GENE; GENE EXPRESSION; GRIFOLA FRONDOSA; HUMAN; HUMAN CELL; KPNA2 GENE; MEDICINAL PLANT; METASTASIS; MUSHROOM; OPHIOCORDYCEPS; PKMYT1 GENE; POLYPORUS UMBELLATUS; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; TFDP1 GENE;

AGARICALES; AGARICUS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CORDYCEPS; CORIOLACEAE; DIETARY SUPPLEMENTS; DOWN-REGULATION; DRUG EVALUATION, PRECLINICAL; DRUGS, CHINESE HERBAL; FEMALE; GRIFOLA; HUMANS; NEOPLASM INVASIVENESS; POLYPORUS; REISHI;

EID: 78649918823     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000806     Document Type: Article

References (86)

1. Wasser SP: Review of medicinal mushroom advances: good news from old allies. HerbalGram 56: 29-33, 2002.
2. Kim HJ, Chang WK, Kim MK, Lee SS and Choi BY: Dietary factors and gastric cancer in Korea: a case-control study. Int J Cancer 97: 531-535, 2002.
3. Hara M, Hanaoka T, Kobayashi M, et al: Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer 46: 138-147, 2003.
4. Zhang M, Huang J, Xie X and Holman CDAJ: Dietary intakes of mushrooms and green tea combine to reduce the risk of breast cancer in Chinese women. Int J Cancer 124: 1404-1408, 2009.
5. Wasser SP: Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biotechnol 60: 258-274, 2002.
6. Borchers AT, Krishnamurthy A, Keen CL, Meyers FJ and Gershwin ME: The immunobiology of mushrooms. Exp Biol Med (Maywood) 233: 259-276, 2008.
7. Mattila P, Suonpaa K and Piironen V: Functional properties of edible mushrooms. Nutrition 16: 694-696, 2000.
8. Zaidman BZ, Yassin M, Mahajna J and Wasser SP: Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67: 453-468, 2005. (Pubitemid 40909591)
9. Mizuno TK: Agaricus blazei Murrill medicinal and dietary effects. Food Rev Int 11: 167-172, 1995.
10. Firenzuoli F, Gori L and Lombardo G: The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmacotoxicological problems. Evid Based Complement Alternat Med 5: 3-15, 2008.
11. Yu CH, Kan SF, Shu CH, Lu TJ, Sun-Hwang L and Wang PS: Inhibitory mechanisms of Agaricus blazei Murill on the growth of prostate cancer in vitro and in vivo. J Nutr Biochem 20: 753-764, 2009.
12. Kim MO, Moon DO, Jung JM, Lee WS, Choi YH and Kim GY: Agaricus blazei Extract Induces Apoptosis through ROS-dependent JNK Activation Involving the Mitochondrial Pathway and Suppression of Constitutive NF-{kappa}B in THP-1 cells. Evid Based Complement Alternat Med [Epub ahead of print], 2009.
13. Niu YC, Liu JC, Zhao XM and Cao J: A low molecular weight polysaccharide isolated from Agaricus blazei Murill (LMPAB) exhibits its anti-metastatic effect by down-regulating metalloproteinase-9 and up-regulating Nm23-H1. Am J Chin Med 37: 909-921, 2009.
14. Wojcikowski K, Johnson DW and Gobé G: Medicinal herbal extracts-renal friend or foe? Part two: herbal extracts with potential renal benefits. Nephrology (Carlton) 9: 400-405, 2004. (Pubitemid 40115967)
15. Zhu JS, Halpern GM and Jones K: The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part II. J Altern Complement Med 4: 429-457, 1998.
16. Shi P, Huang Z, Tan X and Chen G: Proteomic detection of changes in protein expression induced by cordycepin in human hepatocellular carcinoma BEL-7402 cells. Methods Find Exp Clin Pharmacol 30: 347-353, 2008.
17. 3 receptor stimulation. Anticancer Res 26: 43-47, 2006.
18. Thomadaki H, Scorilas A, Tsiapalis CM and Havredaki M: The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner. Cancer Chemother Pharmacol 61: 251-265, 2008.
19. Chen LS, Stellrecht CM and Gandhi V: RNA-directed agent, cordycepin, induces cell death in multiple myeloma cells. Br J Haematol 140: 682-691, 2008.
20. Nakamura K, Konoha K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K and Kunitomo M: Effect of Cordycepin (3′-Deoxyadenosine) on hematogenic lung metastatic model mice. In Vivo 19: 137-141, 2005.
21. Zhang Q, Wu J, Hu Z and Li D: Induction of HL-60 apoptosis by ethyl acetate extract of Cordyceps sinensis fungal mycelium. Life Sci 75: 2911-2919, 2004. (Pubitemid 39349256)
22. Park SE, Yoo HS, Jin CY, et al: Induction of apoptosis and inhibition of telomerase activity in human lung carcinoma cells by the water extract of Cordyceps militaris. Food Chem Toxicol 47: 1667-1675, 2009.
23. Jin CY, Kim GY and Choi YH: Induction of apoptosis by aqueous extract of Cordyceps militaris through activation of caspases and inactivation of Akt in human breast cancer MDA-MB-231 Cells. J Microbiol Biotechnol 18: 1997-2003, 2008.
24. Cui J and Chisti Y: Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv 21: 109-122, 2003. (Pubitemid 36380288)
25. Fisher M and Yang LX: Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res 22: 1737-1754, 2002. (Pubitemid 34839190)
26. Ho CY, Kim CF, Leung KN, Fung KP, Tse TF, Chan H and Lau CB: Differential anti-tumor activity of coriolus versicolor (Yunzhi) extract through p53- and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells. Cancer Biol Ther 4: 638-644, 2005.
27. Hsieh TC, Wu P, Park S and Wu JM: Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP). BMC Complement Altern Med 6: 30, 2006.
28. Jiménez-Medina E, Berruguilla E, Romero I, Algarra I, Collado A, Garrido F and Garcia-Lora A: The immunomodulator PSK induces in vitro cytotoxic activity in tumour cell lines via arrest of cell cycle and induction of apoptosis. BMC Cancer 8: 78, 2008.
29. Wasser SP: Reishi (Ganoderma lucidum). In: Encyclopedia of Dietary Supplements. Marcel Dekker, Taylor & Francis Group, CRC Press, 2005.
30. Gao Y and Zhou S: Cancer prevention and treatment by ganoderma, a mushroom with medical properties. Food Rev Int 19: 275-325, 2003.
31. Lin ZB: Cellular and molecular mechanisms of immunomodulation by Ganoderma lucidum. J Pharm Sci 99: 144-153, 2005. (Pubitemid 41524452)
32. Zhu XL, Chen AF and Lin ZB: Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice. J Ethnopharmacol 111: 219-226, 2007.
33. Toth JO, Luu B and Ourisson G: Les acides ganoderiques T & Z: triterpenes cytotoxiques de Ganoderma lucidum (Polyporacee). Tetrahedron Lett 24: 1081-1084, 1983.
34. Lin CN, Tome WP and Won SJ: Novel cytotoxic principles of Formosan Ganoderma lucidum. J Nat Prod 54: 998-1002, 1991.
35. Min BS, Gao JJ, Nakamura N and Hattori M: Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull 48: 1026-1033, 2000.
36. Gao JJ, Min BS, Ahn EM, Nakamura N, Lee HK and Hattori M: New triterpene aldehydes, lucialdehydes A-C, from Ganoderma lucidum and their cytotoxicity against murine and human tumor cells. Chem Pharm Bull 50: 837-840, 2002.
37. Wu TS, Shi LS and Kuo SC: Cytotoxicity of Ganoderma lucidum triterpenes. J Nat Prod 64: 1121-1122, 2001.
38. Jiang J, Slivova V, Harvey K, Valachovicova T and Sliva D: Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer 49: 209-216, 2004.
39. Sliva D, Sedlak M, Slivova V, Valachovicova T, Lloyd FP Jr and Ho NW: Biologic activity of spores and dried powder from Ganoderma lucidum for the inhibition of highly invasive human breast and prostate cancer cells. J Altern Complement Med 9: 491-497, 2003. (Pubitemid 37051539)
40. Jiang J, Slivova V and Sliva D: Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Int J Oncol 29: 695-703, 2006.
41. Thyagarajan A, Jiang J, Hopf A, Adamec J and Sliva D: Inhibition of oxidative stress-induced invasiveness of cancer cells by Ganoderma lucidum is mediated through the suppression of interleukin-8 secretion. Int J Mol Med 18: 657-664, 2006.
42. Stanley G, Harvey K, Slivova V, Jiang J and Sliva D: Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells. Biochem Biophys Res Commun 330: 46-52, 2005.
43. Ito H, Naruse S and Sugiura M: Studies on antitumor activities of Basidiomycetes-antitumor activity of polysaccharides and sex factors. Nippon Yakurigaku Zasshi 72: 77-94, 1976.
44. Ohno N, Adachi Y, Suzuki I, Oikawa S, Sato K, Ohsawa M and Yadomae T: Antitumor activity of a beta-1,3-glucan obtained from liquid cultured mycelium of Grifola frondosa. J Pharmacobiodyn 9: 861-864, 1986.
45. Kodama N, Komuta K, Sakai N and Nanba H: Effects of D-Fraction, a polysaccharide from Grifola frondosa on tumor growth involve activation of NK cells. Biol Pharm Bull 25: 1647-1650, 2002. (Pubitemid 39663688)
46. Kodama N, Harada N and Nanba H: A polysaccharide, extract from Grifola frondosa, induces Th-1 dominant responses in carcinoma-bearing BALB/c mice. Jpn J Pharmacol 90: 357-360, 2002. (Pubitemid 36096892)
47. Harada N, Kodama N and Nanba H: Relationship between dendritic cells and the D-fraction-induced Th-1 dominant response in BALB/c tumor-bearing mice. Cancer Lett 192: 181-187, 2003.
48. Deng G, Lin H, Seidman A, et al: A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol 135: 1215-1221, 2009.
49. Lee JS, Park SY, Thapa D, et al: Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling. Exp Mol Med [Epub ahead of print], 2010.
50. Shomori K, Yamamoto M, Arifuku I, Teramachi K and Ito H: Antitumor effects of a water-soluble extract from Maitake (Grifola frondosa) on human gastric cancer cell lines. Oncol Rep 22: 615-620, 2009.
51. Li JJ, Tu YY, Tong Jz and Wang PT: Inhibitory activity of Dianthus superbus L. and 11 kinds of diuretic traditional Chinese medicines for urogenital Chlamydia trachomatis in vitro. Zhongguo Zhong Yao Za Zhi 25: 628-630, 2000.
52. Xiong LL: Therapeutic effect of combined therapy of Salvia miltiorrhizae and Polyporus umbellatus polysaccharide in the treatment of chronic hepatitis B. Zhongguo Zhong Xi Yi Jie He Za Zhi 13: 516-535, 1993.
53. Yan SC: Clinical and experimental research on Polyporus umbellatus polysaccharide in the treatment of chronic viral hepatitis. Zhong Xi Yi Jie He Za Zhi 8: 131-143, 1988.
54. Haranaka K, Satomi N, Sakurai A, Haranaka R, Okada N and Kobayashi M: Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol Immunother 20: 1-5, 1985.
55. Chang J: Experimental study of antitumor effect of an extract derived from Zhu-Ling (Polyporus umbellatus). Institute of Materia Medica, Academy of Traditional Chinese Medicine, Peking, China, 1983.
56. You JS, Hau DM, Chen KT and Huang HF: Combined effects of chuling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer. Am J Chin Med 22: 19-28, 1994.
57. Yang DA, Li SQ and Li XT: Prophylactic effects of zhuling and BCG on postoperative recurrence of bladder cancer. Zhonghua Wai Ke Za Zhi 32: 433-434, 1994.
58. Wu GS, Zhang LY and Okuda H: Inhibitive effect of umbellatus polyporus polysaccharide on cachexic manifestation induced by toxohormone-L in rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 17: 232-233, 1997.
59. Ohsawa T, Yukawa M, Takao C, Murayama M and Bando H: Studies on constituents of fruit body of Polyporus umbellatus and their cytotoxic activity. Chem Pharm Bull (Tokyo) 40: 143-147, 1992.
60. Sun Y and Yasukawa K: New anti-inflammatory ergostane-type ecdysteroids from the sclerotium of Polyporus umbellatus. Bioorg Med Chem Lett 18: 3417-3420, 2008.
61. Li B, Allendorf DJ, Hansen R, Marroquin J, Ding C, Cramer DE and Yan J: Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway. J Immunol 177: 1661-1669, 2006.
62. Liu J, Gunn L, Hansen R and Yan J: Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exp Mol Pathol 86: 208-214, 2009.
63. Sliva D, Jedinak A, Kawasaki J, Harvey K and Slivova V: Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling. Br J Cancer 98: 1348-1356, 2008.
64. Jedinak A and Sliva D: Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway. Int J Oncol 33: 1307-1313, 2008.
65. Punglia RS, Morrow M, Winer EP and Harris JR: Local therapy and survival in breast cancer. N Engl J Med 356: 2399-2405, 2007.
66. Tripathy D: Capecitabine in combination with novel targeted agents in the management of metastatic breast cancer: underlying rationale and results of clinical trials. Oncologist 12: 375-389, 2007.
67. Jiang J, Slivova V, Valachovicova T, Harvey K and Sliva D: Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 24: 1093-1099, 2004.
68. Jin CY, Choi YH, Moon DO, et al: Induction of G2/M arrest and apoptosis in human gastric epithelial AGS cells by aqueous extract of Agaricus blazei. Oncol Rep 16: 1349-1355, 2006.
69. Lee SJ, Kim SK, Choi WS, Kim WJ and Moon SK: Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells. Arch Biochem Biophys 490: 103-109, 2009.
70. Hu H, Ahn NS, Yang X, Lee YS and Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102: 250-253, 2002.
71. Lin SB, Li CH, Lee SS and Kan LS: Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72: 2381-2390, 2003.
72. Lu QY, Jin YS, Zhang Q, Zhang Z, Heber D, Go VL, Li FP and Rao JY: Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer Lett 216: 9-20, 2004.
73. Dudhgaonkar S, Thyagarajan A and Sliva D: Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. Int Immunopharmacol 9: 1272-1280, 2009.
74. Heilman DW, Green MR and Teodoro JG: The anaphase promoting complex: a critical target for viral proteins and anticancer drugs. Cell Cycle 4: 560-563, 2005.
75. Prystowsky MB, Adomako A, Smith RV, et al: The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. J Pathol 218: 467-477, 2009.
76. Tsai YS, Chang HC, Chuang LY and Hung WC: RNA silencing of Cks1 induced G2/M arrest and apoptosis in human lung cancer cells. IUBMB Life 57: 583-589, 2005.
77. Wu CC, Chung JG, Tsai SJ, Yang JH and Sheen LY: Differential effects of allyl sulfides from garlic essential oil on cell cycle regulation in human liver tumor cells. Food Chem Toxicol 42: 1937-1947, 2004.
78. Ruetz S, Fabbro D, Zimmermann J, Meyer T and Gray N: Chemical and biological profile of dual Cdk1 and Cdk2 inhibitors. Curr Med Chem Anticancer Agents 3: 1-14, 2003.
79. Choi JK, Murillo G, Su BN, Pezzuto JM, Kinghorn AD and Mehta RG: Ixocarpalactone A isolated from the Mexican tomatillo shows potent antiproliferative and apoptotic activity in colon cancer cells. FEBS J 273: 5714-5723, 2006.
80. Ho YS, Duh JS, Jeng JH, et al: Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells. Int J Cancer 91: 393-401, 2001.
81. Wong NC, Mueller BM, Barbas CF, Ruminski P, Quaranta V, Lin EC and Smith JW: Alphav integrins mediate adhesion and migration of breast carcinoma cell lines. Clin Exp Metastasis 16: 50-61, 1998.
82. Blasi F and Carmeliet P: uPAR: a versatile signaling orchestrator. Nat Rev Mol Cell Biol 3: 932-943, 2002.
83. Kobayashi H, Yoshida R, Kanada Y, et al: Suppressing effects of daily oral supplementation of beta-glucan extracted from Agaricus blazei Murill on spontaneous and peritoneal disseminated metastasis in mouse model. J Cancer Res Clin Oncol 131: 527-538, 2005.
84. Zeng F, Hon CC, Sit WH, et al: Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray. Int J Oncol 27: 513-523, 2005.
85. Müller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
86. Larkins TL, Nowell M, Singh S, and Sanford GL: Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression. BMC Cancer 6: 181, 2006.